SDC1 and Miyoshi myopathy: In addition to the well-known cancer-related function of CD138 as an antigen receptor, its tumorigenic role is enhanced by its dysregulated shedding mechanism, which stimulates migration and angiogenesis of MM cells and overall correlates with poor prognosis and limited therapeutic efficacy (17–19).